<?xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.7.2-ppt (info@mypapit.net)" -->
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>Reuters News Articles By Sam Cage</title>
    <subtitle>Find the latest breaking news from around the world on Reuters.com, including news articles on politics, technology, business, entertainment and more.</subtitle>
    <link rel="alternate" type="text/html" href="http://www.reuters.com/"/>
    <id>http://www.reuters.com/</id>
    <updated>2009-11-26T14:13:23+01:00</updated>
    <generator>FeedCreator 1.7.2-ppt (info@mypapit.net)</generator>
<link rel="self" type="application/atom+xml" href="http://blogs.reuters.com/wp-content/plugins/reuters-author-news-rss-feed/feed.php?author=Sam Cage" />
    <entry>
        <title>UPDATE 3-Novartis strikes licensing deal with Incyte</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/healthcareSector/idUSGEE5AO06D20091125"/>
        <published>2009-11-25T15:29:32+01:00</published>
        <updated>2009-11-25T15:29:32+01:00</updated>
        <id>http://www.reuters.com/article/healthcareSector/idUSGEE5AO06D20091125</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary> * Gains access to 2 therapies for blood disorders, cancers</summary>
    </entry>
    <entry>
        <title>UPDATE 2-Deaths not linked to H1N1 vaccine - WHO</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/COMSRV/idUSLJ60460420091119"/>
        <published>2009-11-19T18:23:07+01:00</published>
        <updated>2009-11-19T18:23:07+01:00</updated>
        <id>http://www.reuters.com/article/COMSRV/idUSLJ60460420091119</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary> * About 40 deaths reported, no link to vaccine established</summary>
    </entry>
    <entry>
        <title>Deaths not linked to H1N1 vaccine - WHO</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/middleeastCrisis/idUSLJ604604"/>
        <published>2009-11-19T18:23:07+01:00</published>
        <updated>2009-11-19T18:23:07+01:00</updated>
        <id>http://www.reuters.com/article/middleeastCrisis/idUSLJ604604</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary>* About 40 deaths reported, no link to vaccine established * Fewer than dozen cases of Guillain-Barre syndrome  (Adds China deaths in new paras 8-9; global death toll, 15) By Stephanie Nebehay GENEVA, Nov 19 (Reuters) - The World Health Organisation said ...</summary>
    </entry>
    <entry>
        <title>Deaths not linked to H1N1 vaccine: WHO</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/GCA-SwineFlu/idUSTRE5AI2BL20091119"/>
        <published>2009-11-19T19:56:40+01:00</published>
        <updated>2009-11-19T19:56:40+01:00</updated>
        <id>http://www.reuters.com/article/GCA-SwineFlu/idUSTRE5AI2BL20091119</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary>GENEVA (Reuters) - The World Health Organization said on Thursday the H1N1 vaccine had been cleared of blame for 41 deaths which health authorities worldwide had investigated after suspicions they might have been caused by the inoculation.</summary>
    </entry>
    <entry>
        <title>UPDATE 2-Deaths not linked to H1N1 vaccine - WHO</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/companyNewsAndPR/idUSLJ60460420091119"/>
        <published>2009-11-19T18:23:07+01:00</published>
        <updated>2009-11-19T18:23:07+01:00</updated>
        <id>http://www.reuters.com/article/companyNewsAndPR/idUSLJ60460420091119</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary> * About 40 deaths reported, no link to vaccine established</summary>
    </entry>
    <entry>
        <title>Deaths not linked to H1N1 vaccine: WHO</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/topNews/idUSTRE5AI2BL20091119"/>
        <published>2009-11-19T19:56:40+01:00</published>
        <updated>2009-11-19T19:56:40+01:00</updated>
        <id>http://www.reuters.com/article/topNews/idUSTRE5AI2BL20091119</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary>GENEVA (Reuters) - The World Health Organization said on Thursday the H1N1 vaccine had been cleared of blame for 41 deaths which health authorities worldwide had investigated after suspicions they might have been caused by the inoculation.</summary>
    </entry>
    <entry>
        <title>Biotech Cosmo aims to buy rival BioXell for $41 mln</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/swissMktRpt/idUSLI5841420091118"/>
        <published>2009-11-18T08:41:47+01:00</published>
        <updated>2009-11-18T08:41:47+01:00</updated>
        <id>http://www.reuters.com/article/swissMktRpt/idUSLI5841420091118</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary> * BioXell shares rise 15 pct, top gainers in Switzerland</summary>
    </entry>
    <entry>
        <title>UPDATE 2-Addex set for partner deal after drug hits target</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/swissMktRpt/idUSLF24355520091116"/>
        <published>2009-11-16T08:42:30+01:00</published>
        <updated>2009-11-16T08:42:30+01:00</updated>
        <id>http://www.reuters.com/article/swissMktRpt/idUSLF24355520091116</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary> * May set up partner deal on potential billion dollar seller</summary>
    </entry>
    <entry>
        <title>Addex lead drug hits target in mid-stage study</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/healthcareSector/idUSZAT01059320091116"/>
        <published>2009-11-16T06:01:57+01:00</published>
        <updated>2009-11-16T06:01:57+01:00</updated>
        <id>http://www.reuters.com/article/healthcareSector/idUSZAT01059320091116</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary> * Expects results from second phase IIb trial in gerd in Jan</summary>
    </entry>
    <entry>
        <title>UBS made no request to buy back toxic assets-press</title>
        <link rel="alternate" type="text/html" href="http://www.reuters.com/article/swissMktRpt/idUSLF62581220091115"/>
        <published>2009-11-15T09:44:45+01:00</published>
        <updated>2009-11-15T09:44:45+01:00</updated>
        <id>http://www.reuters.com/article/swissMktRpt/idUSLF62581220091115</id>
        <author>
            <name>Sam Cage</name>
        </author>
        <summary> ZURICH, Nov 15 (Reuters) - Switzerland's financial regulator
FINMA has received no request from UBS AG &amp;lt;UBSN.VX&amp;gt; to buy back
toxic assets transferred to the Swiss central bank last year,
FINMA's head was quoted on Sunday as saying.</summary>
    </entry>
</feed>
